Genistein derived from soybeans may be considered a valuable therapeutic candidate for prostate cancer, but further experimental validation is needed to gain a comprehensive mechanistic understanding of genistein, particularly focusing on cross-talks between STAT3 and other signaling pathways in cell growth inhibition and apoptosis induction. This evidence concerns the gene STAT3 and Familial prostate cancer.